Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
you guys notice when we are green no noise as soon as we go red the BEARS/SHORTS come out and talk negative or try to cause worry and doubt amongst shareholders 🤣🤣🤣 what a joke cant fool me or the other longs here GO RNVA🤑
you keep talking about 00001 that shit doesn't matter there has been massive ACCUMULATION past few months and barely any SELLS 🤣 keep telling yourself that bullshit story 🤣🤣🤣🤣 GO RNVA good luck BEARS/SHORTS 🤑🤑🤑🤑
same worthless shit you say on GNCP board paid BASHER 🤣🤣🤣🤣 GO RNVA 🤑
you SOLD LOL why still bother lol GO RNVA BEARS ARE SCREWED and they know it we dont need your advice my friend good luck all bears Credibility is gone ceo has done a great job
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.10 Days to Cover
Off-Exchange Short Volume 34,950 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 0.37 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.07 Days to Cover
Off-Exchange Short Volume 1,301,600 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 11.56 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
go RNVA 😎 🤑
Yesterday's DarkPool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.07 Days to Cover
Off-Exchange Short Volume 12,949,696 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 18.78 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.09 Days to Cover
Off-Exchange Short Volume 11,343,400 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 37.98 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Item 1.01 Entry Into a Material Definitive Agreement
On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025; provided, that (subject to the Company then having an effective registration statement covering the applicable number of shares), if Series B Warrants to acquire the following number of shares of common stock are not exercised in the respective periods below (each, an “Exercise Condition”), the termination date of all of the Series B Warrants shall instead be the date the first such Exercise Condition is not satisfied:
From March 21, 2024 to April 15, 2024 1,350,000,000 shares
From April 16, 2024 to August 30, 2024 2,500,000,000 shares
From August 31, 2024 to December 27, 2024 4,000,000,000 shares
From December 28, 2024 to April 24, 2025 4,000,000,000 shares
From April 25, 2025 to August 29, 2025 4,000,000,000 shares
Such share numbers are subject to adjustment in the case of stock splits, combinations, dividends, reclassifications, recapitalizations or other similar events. No cashless exercise of Series B Warrants shall count toward the satisfaction of an Exercise Condition. Other than the Series B Warrants to acquire 101,350,000,000 shares of common stock extended pursuant to the terms of this agreement, warrants to acquire the following number of shares of common stock held by the institutional holders expired on March 21, 2024 pursuant to their terms: Series A Warrants (189,968,328,333 shares); Series B Warrants (23,852,257,133 shares); and Series C Warrants (189,968,321,178 shares). The Company issued a press release on March 26, 2024 announcing the above warrant extension and expirations, a copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
when you say shit like this it blows your cover paid basher 🤣🤣🤣facts.😉
Our common stock is traded on the OTC Pink under the symbol “RNVA.” The last reported sales price of our common stock on March 21, 2024, was $0.0001 per share. There were 43,051,312,711 shares of our common stock outstanding as of March 21, 2024.
with the SHARE BUYBACK INTERESTING 🤔
I wonder will ceo file 10k on time it seems like all timing something is coming 🤑🤑🤑😉
RNVA Retail Ownership 0007 🤑
The Fintel Retail Ownership dataset is created from a large panel of users who share their holdings and transactions with Fintel by linking their broker accounts. The data from these accounts is tracked, aggregated, and published here. We do not share this data with anybody else. Join the panel and receive immediate benefits!
Update Frequency: Daily
See top companies with the most retail ownership.
Date Market Share (%) Funds Flow (%)
2024-03-27 0.0007
yup FACTS ,Smart investors love companies that produce plenty of free cash flow (FCF). It signals a company's ability to pay down debt, pay dividends, buy back stock, and facilitate the growth of the business.
Go RNVA CEO HAS DONE A GREAT JOB
Checkout the Free cash flow
Further, companies that generate the free cash flow (FCF) required to steadily buy back their shares often have the dominant market share and pricing power required to boost the bottom line.
RNVA
free cash flow of $3.73 million.🤑🤑🤑🤑
P.s HEY BEARS DONT GET MAD CEO HAS THE CASH TO BUY SHARES BACK NO BANKRUPTCY
HERE BEARS 🐻 🤣🤣🤣
RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
Piotroski F-Score for Rennova Health, Inc.
In 2000, Joseph Piotroski published a paper titled "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers." This paper described a method of using data from a company's financial reports to help predict future performance.
The Piotroski F-Score, as it is known, is a 9-point discrete score, where 9 is the best, that ranks companies based on a number of financial factors. To calculate the score, we compare nine factors from the two most recent annual reports. If the change in the factor is "good", then we add one to the score. If the change in the factor is "not good", then we add zero. The following explanations are quoted from the paper.
F-Score
8 /9
No BANKRUPTCY HERE BEARS KEEP DREAMING JUST LIKE THE R/S THEORY 🐻🤣🤣🤣🤣
Item 1.01 Entry Into a Material Definitive Agreement
On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025; provided, that (subject to the Company then having an effective registration statement covering the applicable number of shares), if Series B Warrants to acquire the following number of shares of common stock are not exercised in the respective periods below (each, an “Exercise Condition”), the termination date of all of the Series B Warrants shall instead be the date the first such Exercise Condition is not satisfied:
From March 21, 2024 to April 15, 2024 1,350,000,000 shares
From April 16, 2024 to August 30, 2024 2,500,000,000 shares
From August 31, 2024 to December 27, 2024 4,000,000,000 shares
From December 28, 2024 to April 24, 2025 4,000,000,000 shares
From April 25, 2025 to August 29, 2025 4,000,000,000 shares
Such share numbers are subject to adjustment in the case of stock splits, combinations, dividends, reclassifications, recapitalizations or other similar events. No cashless exercise of Series B Warrants shall count toward the satisfaction of an Exercise Condition. Other than the Series B Warrants to acquire 101,350,000,000 shares of common stock extended pursuant to the terms of this agreement, warrants to acquire the following number of shares of common stock held by the institutional holders expired on March 21, 2024 pursuant to their terms: Series A Warrants (189,968,328,333 shares); Series B Warrants (23,852,257,133 shares); and Series C Warrants (189,968,321,178 shares). The Company issued a press release on March 26, 2024 announcing the above warrant extension and expirations, a copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
yup RNVA Margins 🤑 FACTS 😂😉
Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.66%.
Gross Margin 63.10%
Operating Margin 17.96%
Pretax Margin 14.83%
Profit Margin 11.66%
EBITDA Margin 24.45%
EBIT Margin 22.63%
FCF Margin 18.36%
yup Rennova Health had revenue of $20.30M in the twelve months ending September 30, 2023, with 113.44% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.54M with 25.20% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth.
🤑🤑🤑🤑🤑🤑🤑🤑🤑
yup No REVERSE SPLIT FACTS 😉🤑
Lagan stated that there were approximately two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.
To hear Seamus Lagan’s entire interview, follow the link to the podcast here:
https://audioboom.com/posts/8157101-rennova-health-inc-provides-update-to-the-stock-day-podcast.
FACTS ,Smart investors love companies that produce plenty of free cash flow (FCF). It signals a company's ability to pay down debt, pay dividends, buy back stock, and facilitate the growth of the business.
Go RNVA CEO HAS DONE A GREAT JOB
Checkout the Free cash flow
Further, companies that generate the free cash flow (FCF) required to steadily buy back their shares often have the dominant market share and pricing power required to boost the bottom line.
RNVA
free cash flow of $3.73 million.🤑🤑🤑🤑
P.s HEY BEARS DONT GET MAD CEO HAS THE CASH TO BUY SHARES BACK NO BANKRUPTCY
HERE BEARS 🐻 🤣🤣🤣
RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
Piotroski F-Score for Rennova Health, Inc.
In 2000, Joseph Piotroski published a paper titled "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers." This paper described a method of using data from a company's financial reports to help predict future performance.
The Piotroski F-Score, as it is known, is a 9-point discrete score, where 9 is the best, that ranks companies based on a number of financial factors. To calculate the score, we compare nine factors from the two most recent annual reports. If the change in the factor is "good", then we add one to the score. If the change in the factor is "not good", then we add zero. The following explanations are quoted from the paper.
F-Score
8 /9
No BANKRUPTCY HERE BEARS KEEP DREAMING JUST LIKE THE R/S THEORY 🐻🤣🤣🤣🤣
Item 1.01 Entry Into a Material Definitive Agreement
On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025; provided, that (subject to the Company then having an effective registration statement covering the applicable number of shares), if Series B Warrants to acquire the following number of shares of common stock are not exercised in the respective periods below (each, an “Exercise Condition”), the termination date of all of the Series B Warrants shall instead be the date the first such Exercise Condition is not satisfied:
From March 21, 2024 to April 15, 2024 1,350,000,000 shares
From April 16, 2024 to August 30, 2024 2,500,000,000 shares
From August 31, 2024 to December 27, 2024 4,000,000,000 shares
From December 28, 2024 to April 24, 2025 4,000,000,000 shares
From April 25, 2025 to August 29, 2025 4,000,000,000 shares
Such share numbers are subject to adjustment in the case of stock splits, combinations, dividends, reclassifications, recapitalizations or other similar events. No cashless exercise of Series B Warrants shall count toward the satisfaction of an Exercise Condition. Other than the Series B Warrants to acquire 101,350,000,000 shares of common stock extended pursuant to the terms of this agreement, warrants to acquire the following number of shares of common stock held by the institutional holders expired on March 21, 2024 pursuant to their terms: Series A Warrants (189,968,328,333 shares); Series B Warrants (23,852,257,133 shares); and Series C Warrants (189,968,321,178 shares). The Company issued a press release on March 26, 2024 announcing the above warrant extension and expirations, a copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
RNVA Margins 🤑 FACTS 😂😉
Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.66%.
Gross Margin 63.10%
Operating Margin 17.96%
Pretax Margin 14.83%
Profit Margin 11.66%
EBITDA Margin 24.45%
EBIT Margin 22.63%
FCF Margin 18.36%
Rennova Health had revenue of $20.30M in the twelve months ending September 30, 2023, with 113.44% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.54M with 25.20% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth.
🤑🤑🤑🤑🤑🤑🤑🤑🤑
No REVERSE SPLIT FACTS 😉🤑
Lagan stated that there were approximately two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.
To hear Seamus Lagan’s entire interview, follow the link to the podcast here:
https://audioboom.com/posts/8157101-rennova-health-inc-provides-update-to-the-stock-day-podcast.
bears kill me 🤣🤣🤣🤣 such a liar, listen the BEARS manipulation tactics are old, good luck my friend because im going to be here a long time.
🤑🤑🤑🤑🤑🤑
you SOLD LOL why still bother lol GO RNVA BEARS ARE SCREWED and they know it we dont need your advice my friend good luck all bears Credibility is gone ceo has done a great job
Yesterdays Dark pool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.21 Days to Cover
Off-Exchange Short Volume 11,948,000 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 21.69 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
you SOLD LOL why still bother lol GO RNVA BEARS ARE SCREWED and they know it we dont need your advice my friend good luck all bears Credibility is gone ceo has done a great job
i dont think these bears know how fast this could payout remember this has been hit with massive R/Ss in the past years ceo has this company well prepared bears will still try to make others believe it still crappy thats what paid bashers do 🤣
hey BEARS GOOD LUCK 🤣🤣🤣🤑🤑
GO RNVA 😉😎
“The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”
Debt restructuring. We successfully negotiated a debt restructuring with a key institutional lender holding $8.2 million of secured debt in October 2023 to extend the maturity to December 2025 and implement other modifications which waived historical defaults thereby saving default interest in future periods. This restructuring will further improve our balance sheet at December 31, 2023.
“The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”
LOOK BEARS ARE IN DISBELIEF 🤣🤣🤣 DONT WORRY CUBBIES BEARS THERES MORE COMING PAID BASHERS TIME TO PAY UP SOON 😉🤑
Item 1.01 Entry Into a Material Definitive Agreement
On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025; provided, that (subject to the Company then having an effective registration statement covering the applicable number of shares), if Series B Warrants to acquire the following number of shares of common stock are not exercised in the respective periods below (each, an “Exercise Condition”), the termination date of all of the Series B Warrants shall instead be the date the first such Exercise Condition is not satisfied:
From March 21, 2024 to April 15, 2024 1,350,000,000 shares
From April 16, 2024 to August 30, 2024 2,500,000,000 shares
From August 31, 2024 to December 27, 2024 4,000,000,000 shares
From December 28, 2024 to April 24, 2025 4,000,000,000 shares
From April 25, 2025 to August 29, 2025 4,000,000,000 shares
Such share numbers are subject to adjustment in the case of stock splits, combinations, dividends, reclassifications, recapitalizations or other similar events. No cashless exercise of Series B Warrants shall count toward the satisfaction of an Exercise Condition. Other than the Series B Warrants to acquire 101,350,000,000 shares of common stock extended pursuant to the terms of this agreement, warrants to acquire the following number of shares of common stock held by the institutional holders expired on March 21, 2024 pursuant to their terms: Series A Warrants (189,968,328,333 shares); Series B Warrants (23,852,257,133 shares); and Series C Warrants (189,968,321,178 shares). The Company issued a press release on March 26, 2024 announcing the above warrant extension and expirations, a copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
you guys noticed SHARE BUY BACK rite before
10k release 🤑
BEARS KEEP UP THE GOOD WORK CLOWNS 🤣🤡🤡🤡🤡🤡🤡🤡🤡🤡🤡
RNVA IS ABOUT TO GET CRAZY FOR BEARS 🤣BEARS CAN TALK ALL THE SHIT THEY WANT 😉🤑🤑🤑🤑🤑🤑🤑🤑🤑
FACTS ,Smart investors love companies that produce plenty of free cash flow (FCF). It signals a company's ability to pay down debt, pay dividends, buy back stock, and facilitate the growth of the business.
Go RNVA CEO HAS DONE A GREAT JOB
Checkout the Free cash flow
Further, companies that generate the free cash flow (FCF) required to steadily buy back their shares often have the dominant market share and pricing power required to boost the bottom line.
RNVA
free cash flow of $3.73 million.🤑🤑🤑🤑
P.s HEY BEARS DONT GET MAD CEO HAS THE CASH TO BUY SHARES BACK NO BANKRUPTCY
HERE BEARS 🐻 🤣🤣🤣
RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
only bears/shorts/paid bashers Will talk negative about a stock every day us shareholders
see rite through your shit my friend all you bears have no CREDIBILITY at all go RNVA
yup ok you are EXTREMELY BEARISH because you got BURNT in the past FACTS thanks for the heads up plain and simple lol good luck my friend
totally different circumstances in RNVA
You been bearish from day one bro cant fool anyone anymore 🐻
P.s i bet you never even had shares i bet you been a naked short this whole time time to pay up soon
we all know turtle sold 🤣 thats what he says or he just been a naked short this whole time go RNVA time to pay up real soon